PAR2 response in fluid flow-stimulated chondrocytes

Carmen Huesa, E Williamson, U Kreuser, Gary Litherland, John Lockhart, William R. Ferrell

Research output: Contribution to conferenceAbstract

3 Downloads (Pure)

Abstract

Osteoarthritis (OA) is a heterogeneous musculoskeletal disease. We have compelling evidence that proteinaseactivated receptor-2 (PAR2) is a mediator of OA initiation/progression, integrating matrix deregulation and tissue remodeling/infl ammatory damage. PAR2 offers a potentially novel therapeutic target in OA. The onset of OA has mechanical “damage” as a common denominator and we have observed elevated of PAR2 in articular chondrocytes during the OA mouse destabilization of the medial meniscus (DMM) model and in human OA cartilage. PAR2 was also found in osteocytes. Whilst wild type animals exhibit rapid osteophyte formation, PAR2-defi cient (PAR2−/−) mice are substantially protected from this process (osteophyte formation = 92.3% in WT, vs. 45.5% in PAR2−/− mice, and the latter were signifi cantly smaller, WT = 2.50 ± 0.27, PAR2−/− = 0.41 ± 0.19 μm3). Osteosclerosis was signifi cant by day 14 in WT (P = 0.023) and remained so at day 28 (P = 0.019) whilst PAR2−/− mice showed no signifi cant osteosclerosis at either day 14 or 28, potentially indicating a slower response to the mechanical changes induced by DMM surgery. This led us to question whether PAR2 may play a role in mechanotransduction. Murine osteocyte-like cells (MLOY4) were stimulated with 7 dyn/cm2 of fl uid fl ow shear stress (FSS) and human chondrocyte-like cells (SW1353) with physiological (5 dyn/cm2) and pathophysiological (20 dyn/cm2) FSS for 1 h. During FSS, MLOY4s were administered 10 nM PAR2 activating peptide SLIGRL or control reverse peptide. Immunofl uorescence and western blotting showed intrinsic PAR2 presence in MLOY4s, which did not change after FSS stimulation. FSS increased COX2 gene expression 4-fold (P < 0.01). SLIGRL in static conditions induced a 2-fold increase in IL-6 expression, which was reduced to static control levels after FSS (P < 0.01). No other parameters were signifi cant. SW1353s did not contain intrinsic PAR2 under static conditions, yet a marked increase was noted upon stimulation with FSS (mean grey value ± SD: static control, comparable to background, = 92 ± 5.6, 5 dyn = 226 ± 23, 20 dyn = 191 ± 22, P < 0.001, 1way ANOVA). This FSS-induced increase in PAR2 suggests that altered biomechanical loading may initiate PAR2 mediated mechanisms ultimately leading to cartilage degradation, which could have implications for human disease.
Original languageEnglish
Pages36
Number of pages1
Publication statusPublished - 1 Sep 2015
EventBone Research Society Joint Meeting - Edinburgh, United Kingdom
Duration: 1 Mar 20153 Mar 2015
https://boneresearchsociety.org/meeting/edinburgh2015/

Conference

ConferenceBone Research Society Joint Meeting
CountryUnited Kingdom
CityEdinburgh
Period1/03/153/03/15
Internet address

Fingerprint

Chondrocytes
Osteoarthritis
seryl-leucyl-isoleucyl-glycyl-arginyl-leucine
Tibial Meniscus
Osteophyte
Osteocytes
Cartilage
Osteosclerosis
Musculoskeletal Diseases
Peptides
Wild Animals
Interleukin-6
Analysis of Variance
Joints

Keywords

  • Chondrocytes
  • PAR2

Cite this

Huesa, C., Williamson, E., Kreuser, U., Litherland, G., Lockhart, J., & Ferrell, W. R. (2015). PAR2 response in fluid flow-stimulated chondrocytes. 36. Abstract from Bone Research Society Joint Meeting, Edinburgh, United Kingdom.
Huesa, Carmen ; Williamson, E ; Kreuser, U ; Litherland, Gary ; Lockhart, John ; Ferrell, William R. . / PAR2 response in fluid flow-stimulated chondrocytes. Abstract from Bone Research Society Joint Meeting, Edinburgh, United Kingdom.1 p.
@conference{5b7ddfe8e61b498c8f32729d5e412036,
title = "PAR2 response in fluid flow-stimulated chondrocytes",
abstract = "Osteoarthritis (OA) is a heterogeneous musculoskeletal disease. We have compelling evidence that proteinaseactivated receptor-2 (PAR2) is a mediator of OA initiation/progression, integrating matrix deregulation and tissue remodeling/infl ammatory damage. PAR2 offers a potentially novel therapeutic target in OA. The onset of OA has mechanical “damage” as a common denominator and we have observed elevated of PAR2 in articular chondrocytes during the OA mouse destabilization of the medial meniscus (DMM) model and in human OA cartilage. PAR2 was also found in osteocytes. Whilst wild type animals exhibit rapid osteophyte formation, PAR2-defi cient (PAR2−/−) mice are substantially protected from this process (osteophyte formation = 92.3{\%} in WT, vs. 45.5{\%} in PAR2−/− mice, and the latter were signifi cantly smaller, WT = 2.50 ± 0.27, PAR2−/− = 0.41 ± 0.19 μm3). Osteosclerosis was signifi cant by day 14 in WT (P = 0.023) and remained so at day 28 (P = 0.019) whilst PAR2−/− mice showed no signifi cant osteosclerosis at either day 14 or 28, potentially indicating a slower response to the mechanical changes induced by DMM surgery. This led us to question whether PAR2 may play a role in mechanotransduction. Murine osteocyte-like cells (MLOY4) were stimulated with 7 dyn/cm2 of fl uid fl ow shear stress (FSS) and human chondrocyte-like cells (SW1353) with physiological (5 dyn/cm2) and pathophysiological (20 dyn/cm2) FSS for 1 h. During FSS, MLOY4s were administered 10 nM PAR2 activating peptide SLIGRL or control reverse peptide. Immunofl uorescence and western blotting showed intrinsic PAR2 presence in MLOY4s, which did not change after FSS stimulation. FSS increased COX2 gene expression 4-fold (P < 0.01). SLIGRL in static conditions induced a 2-fold increase in IL-6 expression, which was reduced to static control levels after FSS (P < 0.01). No other parameters were signifi cant. SW1353s did not contain intrinsic PAR2 under static conditions, yet a marked increase was noted upon stimulation with FSS (mean grey value ± SD: static control, comparable to background, = 92 ± 5.6, 5 dyn = 226 ± 23, 20 dyn = 191 ± 22, P < 0.001, 1way ANOVA). This FSS-induced increase in PAR2 suggests that altered biomechanical loading may initiate PAR2 mediated mechanisms ultimately leading to cartilage degradation, which could have implications for human disease.",
keywords = "Chondrocytes, PAR2",
author = "Carmen Huesa and E Williamson and U Kreuser and Gary Litherland and John Lockhart and Ferrell, {William R.}",
year = "2015",
month = "9",
day = "1",
language = "English",
pages = "36",
note = "Bone Research Society Joint Meeting ; Conference date: 01-03-2015 Through 03-03-2015",
url = "https://boneresearchsociety.org/meeting/edinburgh2015/",

}

Huesa, C, Williamson, E, Kreuser, U, Litherland, G, Lockhart, J & Ferrell, WR 2015, 'PAR2 response in fluid flow-stimulated chondrocytes' Bone Research Society Joint Meeting, Edinburgh, United Kingdom, 1/03/15 - 3/03/15, pp. 36.

PAR2 response in fluid flow-stimulated chondrocytes. / Huesa, Carmen; Williamson, E; Kreuser, U; Litherland, Gary; Lockhart, John; Ferrell, William R. .

2015. 36 Abstract from Bone Research Society Joint Meeting, Edinburgh, United Kingdom.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - PAR2 response in fluid flow-stimulated chondrocytes

AU - Huesa, Carmen

AU - Williamson, E

AU - Kreuser, U

AU - Litherland, Gary

AU - Lockhart, John

AU - Ferrell, William R.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Osteoarthritis (OA) is a heterogeneous musculoskeletal disease. We have compelling evidence that proteinaseactivated receptor-2 (PAR2) is a mediator of OA initiation/progression, integrating matrix deregulation and tissue remodeling/infl ammatory damage. PAR2 offers a potentially novel therapeutic target in OA. The onset of OA has mechanical “damage” as a common denominator and we have observed elevated of PAR2 in articular chondrocytes during the OA mouse destabilization of the medial meniscus (DMM) model and in human OA cartilage. PAR2 was also found in osteocytes. Whilst wild type animals exhibit rapid osteophyte formation, PAR2-defi cient (PAR2−/−) mice are substantially protected from this process (osteophyte formation = 92.3% in WT, vs. 45.5% in PAR2−/− mice, and the latter were signifi cantly smaller, WT = 2.50 ± 0.27, PAR2−/− = 0.41 ± 0.19 μm3). Osteosclerosis was signifi cant by day 14 in WT (P = 0.023) and remained so at day 28 (P = 0.019) whilst PAR2−/− mice showed no signifi cant osteosclerosis at either day 14 or 28, potentially indicating a slower response to the mechanical changes induced by DMM surgery. This led us to question whether PAR2 may play a role in mechanotransduction. Murine osteocyte-like cells (MLOY4) were stimulated with 7 dyn/cm2 of fl uid fl ow shear stress (FSS) and human chondrocyte-like cells (SW1353) with physiological (5 dyn/cm2) and pathophysiological (20 dyn/cm2) FSS for 1 h. During FSS, MLOY4s were administered 10 nM PAR2 activating peptide SLIGRL or control reverse peptide. Immunofl uorescence and western blotting showed intrinsic PAR2 presence in MLOY4s, which did not change after FSS stimulation. FSS increased COX2 gene expression 4-fold (P < 0.01). SLIGRL in static conditions induced a 2-fold increase in IL-6 expression, which was reduced to static control levels after FSS (P < 0.01). No other parameters were signifi cant. SW1353s did not contain intrinsic PAR2 under static conditions, yet a marked increase was noted upon stimulation with FSS (mean grey value ± SD: static control, comparable to background, = 92 ± 5.6, 5 dyn = 226 ± 23, 20 dyn = 191 ± 22, P < 0.001, 1way ANOVA). This FSS-induced increase in PAR2 suggests that altered biomechanical loading may initiate PAR2 mediated mechanisms ultimately leading to cartilage degradation, which could have implications for human disease.

AB - Osteoarthritis (OA) is a heterogeneous musculoskeletal disease. We have compelling evidence that proteinaseactivated receptor-2 (PAR2) is a mediator of OA initiation/progression, integrating matrix deregulation and tissue remodeling/infl ammatory damage. PAR2 offers a potentially novel therapeutic target in OA. The onset of OA has mechanical “damage” as a common denominator and we have observed elevated of PAR2 in articular chondrocytes during the OA mouse destabilization of the medial meniscus (DMM) model and in human OA cartilage. PAR2 was also found in osteocytes. Whilst wild type animals exhibit rapid osteophyte formation, PAR2-defi cient (PAR2−/−) mice are substantially protected from this process (osteophyte formation = 92.3% in WT, vs. 45.5% in PAR2−/− mice, and the latter were signifi cantly smaller, WT = 2.50 ± 0.27, PAR2−/− = 0.41 ± 0.19 μm3). Osteosclerosis was signifi cant by day 14 in WT (P = 0.023) and remained so at day 28 (P = 0.019) whilst PAR2−/− mice showed no signifi cant osteosclerosis at either day 14 or 28, potentially indicating a slower response to the mechanical changes induced by DMM surgery. This led us to question whether PAR2 may play a role in mechanotransduction. Murine osteocyte-like cells (MLOY4) were stimulated with 7 dyn/cm2 of fl uid fl ow shear stress (FSS) and human chondrocyte-like cells (SW1353) with physiological (5 dyn/cm2) and pathophysiological (20 dyn/cm2) FSS for 1 h. During FSS, MLOY4s were administered 10 nM PAR2 activating peptide SLIGRL or control reverse peptide. Immunofl uorescence and western blotting showed intrinsic PAR2 presence in MLOY4s, which did not change after FSS stimulation. FSS increased COX2 gene expression 4-fold (P < 0.01). SLIGRL in static conditions induced a 2-fold increase in IL-6 expression, which was reduced to static control levels after FSS (P < 0.01). No other parameters were signifi cant. SW1353s did not contain intrinsic PAR2 under static conditions, yet a marked increase was noted upon stimulation with FSS (mean grey value ± SD: static control, comparable to background, = 92 ± 5.6, 5 dyn = 226 ± 23, 20 dyn = 191 ± 22, P < 0.001, 1way ANOVA). This FSS-induced increase in PAR2 suggests that altered biomechanical loading may initiate PAR2 mediated mechanisms ultimately leading to cartilage degradation, which could have implications for human disease.

KW - Chondrocytes

KW - PAR2

UR - https://www.frontiersin.org/books/Bone_Research_Society_2015/700

M3 - Abstract

SP - 36

ER -

Huesa C, Williamson E, Kreuser U, Litherland G, Lockhart J, Ferrell WR. PAR2 response in fluid flow-stimulated chondrocytes. 2015. Abstract from Bone Research Society Joint Meeting, Edinburgh, United Kingdom.